Sign in →

Fragile X Syndrome

Collection Requirements

Source: blood
Container: EDTA lavender
Volume:

  • Preferred: 3 mL in vacutainer
  • Minimum: 1 mL in vacutainer

 

Source: buccal/saliva
Container: OraCollect Kit

Turn Around Time

21 days

Availability

Routine

Lab Processing Instructions

Specimen: whole blood
Room temperature or refrigerate

 

Specimen: buccal/saliva
Room temperature

Performing Laboratory

Adele Hall

Adele Hall Lab Section

Molecular Genetics

Instrumentation/Methodology

CGG repeat sizing by PCR fragment analysis

Additional Information

Fragile X Syndrome is a trinucleotide expansion repeat disorder characterized by moderate intellectual disability and subtle dysmorphic features in affected males and variable symptoms in affected females. Affected individuals have an abnormal expansion of a CGG repeat tract in the 5’-unstranslated region of the FMR1 gene on the X chromosome (>200 CGG repeats, i.e. a full mutation). Males with CGG repeats in the premutation range (55-200) have increased risk for Fragile X Tremor/Ataxia Syndrome (FXTAS). Females with a premutation have an increased risk for Primary Ovarian Insufficiency (POI).

Reference Ranges

See interpretive report

CPT

81243